ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,224Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 939

$883K Total Retail Price of All Prescriptions

Rank: 66 out of 939

683 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 683 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 683 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 11,746 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 628 468 1 7
LISINOPRIL 573 426 2 3
HYDROCODONE-ACETAMINOPHEN 490 316 S3 3 1
LEVOTHYROXINE SODIUM 473 385 4 4
SIMVASTATIN 436 332 5 2
POTASSIUM CHLORIDE 402 287 6 9
GABAPENTIN 399 268 7 11
AMLODIPINE BESYLATE 398 326 8 6
METFORMIN HCL 376 249 9 8
OMEPRAZOLE 370 314 10 5
MELOXICAM 342 237 11 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 287 210 12 23
TRAMADOL HCL 279 160 13 16
METOPROLOL TARTRATE 259 198 14 10
NEXIUM 242 158 15 18
PAROXETINE HCL 231 145 16 70
WARFARIN SODIUM 201 147 17 17
PREDNISONE 196 135 18 42
ALLOPURINOL 185 129 19 31
SERTRALINE HCL 182 165 20 24
PRAVASTATIN SODIUM 175 137 21 13
CITALOPRAM HBR 173 139 22 15
AMITRIPTYLINE HCL 164 65 R 23 38
ATENOLOL 157 109 24 19
POLYETHYLENE GLYCOL 3350 144 113 25 57
FLUOXETINE HCL 129 96 26 47
ZOLPIDEM TARTRATE 128 85 27 20
METOCLOPRAMIDE HCL 126 104 28 119
TAMSULOSIN HCL 126 91 28 27
QUETIAPINE FUMARATE 121 91 30 69
BACLOFEN 120 62 31 157
DOXYCYCLINE HYCLATE 117 69 32 84
HYDROCHLOROTHIAZIDE 116 76 33 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 115 85 34 64
FAMOTIDINE 110 52 35 62
ROPINIROLE HCL 102 74 36 78
ATORVASTATIN CALCIUM 101 85 37 22
ABILIFY 101 36 37 156
CLONIDINE HCL 98 50 39 39
TIZANIDINE HCL 96 41 40 81
METOPROLOL SUCCINATE 96 72 40 21
CLOPIDOGREL 92 48 42 28
ESCITALOPRAM OXALATE 90 46 43 61
CRESTOR 89 72 44 34
ISOSORBIDE MONONITRATE ER 88 68 45 53
MIRTAZAPINE 87 70 46 56
NAMENDA 85 85 47 49
DIVALPROEX SODIUM 84 32 48 95
GLIPIZIDE 81 65 49 52
LEVETIRACETAM 80 49 50 170
DONEPEZIL HCL 79 78 51 30
SEROQUEL 78 72 52 139
TRAZODONE HCL 78 54 52 26
LANTUS 76 36 54 59
LOVAZA 76 12 54 191
AMLODIPINE BESYLATE-BENAZEPRIL 75 72 56 58
BENZTROPINE MESYLATE 72 32 R 57 175
VENTOLIN HFA 72 47 57 80
AGGRENOX 72 61 57 153
SPIRIVA 71 55 60 73
DEXAMETHASONE 70 45 61 307
PHENYTOIN SODIUM EXTENDED 70 52 61 99
PROAIR HFA 69 42 63 41
TRIAMTERENE-HCTZ 68 50 64 33
ALENDRONATE SODIUM 67 51 65 40
FLUTICASONE PROPIONATE 67 29 65 43
CARVEDILOL 65 36 67 25
GLIPIZIDE XL 65 55 67 147
EXELON 62 62 69 151
COMBIVENT 60 25 70 120
SUCRALFATE 59 35 71 96
NYSTATIN 59 27 71 174
VESICARE 59 49 71 202
SEROQUEL XR 58 19 74 230
MECLIZINE HCL 58 55 74 134
BENICAR HCT 58 58 74 243
CYCLOBENZAPRINE HCL 57 17 R 77 36
CIPROFLOXACIN HCL 56 40 78 54
PLAVIX 55 38 79 48
DICYCLOMINE HCL 55 38 79 194
ADVAIR DISKUS 52 29 81 60
FENOFIBRATE 50 29 82 83
TOPIRAMATE 50 12 82 154
CLOZAPINE 50 0 82 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.